Hydralazine Hydrochloride Tablet
Product Images NDC 70518-4022

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 70518-4022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Hydralazine Hydrochloride 10 mg oral tablets, packaged in a quantity of 30 tablets. The label shows the drug name, strength, dosage form, and quantity. It includes NDC 70518-4022-00, manufacturer information (Avet Pharmaceuticals Inc., East Brunswick, NJ), and repackager details (RemedyRepack Inc., Indiana, PA). Additional text includes storage instructions and a barcode with a QR code.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of Hydralazine Hydrochloride showing the molecular formula C8H8N4 with HCl and molecular weight 196.64.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.